Anti-Hyperglycemic Medication Management in the Perioperative Setting: A Review and Illustrative Case of an Adverse Effect of GLP-1 Receptor Agonist
- PMID: 39458209
- PMCID: PMC11509032
- DOI: 10.3390/jcm13206259
Anti-Hyperglycemic Medication Management in the Perioperative Setting: A Review and Illustrative Case of an Adverse Effect of GLP-1 Receptor Agonist
Abstract
A host of anti-hyperglycemic agents are currently available and widely prescribed for diabetes and weight loss management. In patients undergoing surgery, use of these agents poses a clinical challenge to surgeons, anesthesiologists, and other perioperative care providers with regard to optimal timing of discontinuation and resumption of use, as well as possible effects of these agents on physiology and risk of postoperative complications. Here, we provide a comprehensive review of anti-hyperglycemic medications' effects on physiology, risks/benefits, and best practice management in the perioperative setting. Additionally, we report an illustrative case of small bowel obstruction in a patient taking semaglutide for 6 months prior to an otherwise uncomplicated laparoscopic hysterectomy and bilateral salpingo-oophorectomy. This review is meant to serve not as a replacement of, but rather as a consolidated complement to, various society guidelines regarding perioperative anti-hyperglycemic agent management.
Keywords: GLP-1 receptor agonists; anti-hyperglycemic agents; perioperative care; pharmacovigilance.
Conflict of interest statement
The authors have no relevant conflicts of interest.
Figures

Similar articles
-
The Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Perioperative Period: A Case Study.Cureus. 2025 Jan 7;17(1):e77106. doi: 10.7759/cureus.77106. eCollection 2025 Jan. Cureus. 2025. PMID: 39917093 Free PMC article.
-
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 38309959 Chinese.
-
Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report.Can J Anaesth. 2023 Aug;70(8):1397-1400. doi: 10.1007/s12630-023-02521-3. Epub 2023 Jun 6. Can J Anaesth. 2023. PMID: 37280458 English.
-
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations.Can J Anaesth. 2024 Sep;71(9):1302-1315. doi: 10.1007/s12630-024-02810-5. Epub 2024 Aug 26. Can J Anaesth. 2024. PMID: 39187641 Review. English.
-
Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists.Adv Ther. 2021 Jun;38(6):2821-2839. doi: 10.1007/s12325-021-01710-0. Epub 2021 May 11. Adv Ther. 2021. PMID: 33977495 Free PMC article. Review.
Cited by
-
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss.Biomolecules. 2025 Mar 13;15(3):408. doi: 10.3390/biom15030408. Biomolecules. 2025. PMID: 40149944 Free PMC article. Review.
References
-
- Joshi G.P., Chung F., Vann M.A., Ahmad S., Gan T.J., Goulson D.T., Merrill D.G., Twersky R. Society for Ambulatory Anesthesia Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery. Anesth. Analg. 2010;111:1378–1387. doi: 10.1213/ANE.0b013e3181f9c288. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources